Leonard Saltz
机构: Professor of Medicine, Weill Cornell Medical College and Memorial Sloan Kettering Cancer Center
每年引用次数
引用次数
引用: 87,979
H-指数: 150
I10-指数 : 438
出版物: 863
Universal screening for microsatellite instability in colorectal cancer in the clinical genomics era: new recommendations, methods, and considerations
Jaclyn F. Hechtman , Sumit Middha , Zsofia K. Stadler , Ahmet Zehir
Familial Cancer 16 ( 4) 525 -529
12
2017
L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer
Karuna Ganesh , Harihar Basnet , Yasemin Kaygusuz , Ashley M. Laughney
Nature Cancer 1 ( 1) 28 -45
117
2020
Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors.
Jeremy Kortmansky , Manish A. Shah , Andreas Kaubisch , Amanda Weyerbacher
Journal of Clinical Oncology 23 ( 9) 1875 -1884
92
2005
Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Ghassan K. Abou-Alfa , Lawrence Schwartz , Sergio Ricci , Dino Amadori
Journal of Clinical Oncology 24 ( 26) 4293 -4300
1,508
2006
100 High dose rate intraoperative brachytherapy for recurrent colorectal cancer
Kaled M. Alektiar , Michael J. Zelefsky , Philip B. Paty , Jose Guillem
Radiotherapy and Oncology 55 57
2000
Abstract CT211: IMMU-130, an SN-38 antibody-drug conjugate (ADC) targeting CEACAM5, is therapeutically active in metastatic colorectal cancer (mCRC): Initial clinical results of two Phase I studies
Neil H. Segal , Efrat Dotan , Jordan D. Berlin , Alexander N. Starodub
Cancer Research 74
21
2014
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
Jinru Shia , Laura H. Tang , Martin R. Weiser , Baruch Brenner
The American Journal of Surgical Pathology 32 ( 5) 719 -731
122
2008
Palliative Care in the Outpatient Oncology Setting: Evaluation of a Practical Set of Referral Criteria
Paul A. Glare , Deborah Semple , Stacy M. Stabler , Leonard B. Saltz
Journal of Oncology Practice 7 ( 6) 366 -370
45
2011
Colorectal cancer survivors' needs and preferences for survivorship information.
Talya Salz , Shrujal S. Baxi , Victoria S. Blinder , Elena B. Elkin
Journal of Oncology Practice 10 ( 4)
18
2014
Hospitalists on an Inpatient Tertiary Care Oncology Teaching Service
Douglas J. Koo , Tabitha N. Goring , Leonard B. Saltz , Marina Kerpelev
Journal of Oncology Practice 11 ( 2)
4
2015
Faster FOLFOX: Oxaliplatin Can Be Safely Infused at a Rate of 1 mg/m2/min
Andrea Cercek , Vivian Park , Rona Yaeger , Diane Reidy-Lagunes
Journal of Oncology Practice 12 ( 5)
2016
OncoKB: A Precision Oncology Knowledge Base.
Ahmet Zehir , Michael F. Berger , Barry S. Taylor , Leonard B. Saltz
JCO precision oncology 2017 ( 1) 1 -16
1,450
2017
Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability
Nitya Raj , Ronak Shah , Zsofia Stadler , Semanti Mukherjee
JCO Precision Oncology 2018 ( 2) 1 -18
17
2018
Multivitamin Use Is Not Associated With Cancer Recurrence or Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803
Kimmie Ng , Jeffrey A. Meyerhardt , Jennifer A. Chan , Donna Niedzwiecki
Journal of Clinical Oncology 28 ( 28) 4354 -4363
26
2010
Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa.
Rohit Bhargava , Beiyun Chen , David S. Klimstra , Leonard B. Saltz
Cancer 106 ( 8) 1857 -1862
39
2006
Pathologic stage is most prognostic of disease‐free survival in locally advanced rectal cancer patients after preoperative chemoradiation
Hak‐Mien Quah , Joanne F. Chou , Mithat Gonen , Jinru Shia
Cancer 113 ( 1) 57 -64
192
2008
Treatment Options for Patients With Unresectable Colorectal Cancer With Wild-Type KRAS
Leonard B. Saltz
Current Colorectal Cancer Reports 8 ( 3) 170 -176
2012
Translational Considerations on the Outlook of Immunotherapy for Colorectal Cancer
Neil H. Segal , Leonard B. Saltz
Current Colorectal Cancer Reports 11 ( 2) 92 -97
4
2015
Oxaliplatin and irinotecan: From advanced to adjuvant therapy of colon cancer
Ki Young Chung , Leonard B. Saltz
Current Colorectal Cancer Reports 2 ( 3) 142 -148
2006
A phase I expansion study of trifluridine and tipiracil (FTD/TPI) in combination with irinotecan (IRI) and bevacizumab (BEV) in patients with metastatic colorectal cancer (mCRC).
Anna M. Varghese , Dana Backlund Cardin , Jonathan Hersch , Al Bowen Benson
Journal of Clinical Oncology 36 3546 -3546
2018